Clinical Trial: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access
Official Title: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Brief Summary: This is a single patient compassionate use protocol to determine whether RAVICTI will improve bile flow in a subject who previously tolerated therapy with Buphenyl.
Detailed Summary:
Sponsor: University of Pittsburgh
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Pittsburgh
Dates:
Date Received: September 20, 2013
Date Started:
Date Completion:
Last Updated: September 20, 2013
Last Verified: September 2013